vectoroncology.com
Novel Receptor Tyrosine Kinase Targeted Combination Therapies for Imatinib-resistant Gastrointestinal Stromal Tumors (GIST)
[embeddoc url="http://www.vectoroncology.com/articles/oncoTarget1214mahadevan.pdf" viewer="google"]